AbbVie Stock Jumped Today: Deal Sparks New Outlook for Investors
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
This explains the function of the index divisor for investors, including how it influences observed returns and analysis.
26,233 articlesAbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
The chip market has cooled as investors weigh AI infrastructure costs. This piece highlights three AI chip stocks to ...
The 2026 software stock sell-off has traders buzzing, even as many companies post solid results. Is AI disruption fea...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
The AI boom has turned Nvidia and AMD into poster children for opportunity—and risk. This guide breaks down the signa...
SpaceX is speeding up its IPO timeline, shaking up the investing world. This guide breaks down 10 essential what-to-k...
A bold new plan could reshape crypto funding: a $300 million preferred stock sale to back an ETH-heavy treasury built...
Investors are eyeing the microreactor trend and Nano Nuclear Energy. This guide breaks down the potential, risks, and...
When two tech giants renew a crucial chip deal, markets react fast. Discover how the Broadcom collaboration could sha...
As Herbalife wraps up 2025, investors seek clarity on growth, margins, and the path ahead. This article breaks down w...
Portillo's has faced growth and branding challenges that threaten its future. This guide breaks down what a comeback ...
Robinhood enters 2026 with expanded features and crypto access, while scrutiny tightens around fees and security. Thi...